These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 18353539)

  • 1. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma.
    Lu ZX; Ma XQ; Yang LF; Wang ZL; Zeng L; Li ZJ; Li XN; Tang M; Yi W; Gong JP; Sun LQ; Cao Y
    Cancer Lett; 2008 Jul; 265(2):226-38. PubMed ID: 18353539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis.
    Lu ZX; Ye M; Yan GR; Li Q; Tang M; Lee LM; Sun LQ; Cao Y
    Cancer Gene Ther; 2005 Jul; 12(7):647-54. PubMed ID: 15803142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhibition of EBV-encoded latent membrane protein-1 by small interfering RNA on EBV-positive nasopharyngeal carcinoma cell growth.
    Li G; Li XP; Peng Y; Liu X; Li XH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):241-6. PubMed ID: 15041532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of Epstein-Barr virus latent membrane protein 1(EBV-LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1].
    Gou XM; Chen Y; Chen XY; Arrand JR
    Ai Zheng; 2003 May; 22(5):481-5. PubMed ID: 12753707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases.
    Wu CJ; Leu CY; Liu ST; Chow KP; Meng CL; Chang YS
    Gene Ther; 1998 Jul; 5(7):905-12. PubMed ID: 9813661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1].
    Chen Y; Chen XY
    Ai Zheng; 2002 May; 21(5):498-503. PubMed ID: 12452040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A therapeutic approach to nasopharyngeal carcinomas by DNAzymes targeting EBV LMP-1 gene.
    Yang L; Lu Z; Ma X; Cao Y; Sun LQ
    Molecules; 2010 Sep; 15(9):6127-39. PubMed ID: 20877211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence visualization screening for EBV-LMP1-targeted DNAzymes.
    You X; Yang YC; Ke X; Hong SL; Hu GH
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):251-8. PubMed ID: 24323909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
    Zheng H; Li LL; Hu DS; Deng XY; Cao Y
    Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent membrane protein-1 of Epstein - Barr virus increases sensitivity to arsenic trioxide-induced apoptosis in nasopharyngeal carcinoma cell.
    Du CW; Wen BG; Li DR; Lin YC; Zheng YW; Chen L; Chen JY; Lin W; Wu MY
    Exp Oncol; 2005 Dec; 27(4):267-72. PubMed ID: 16404345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.
    Keryer-Bibens C; Pioche-Durieu C; Villemant C; Souquère S; Nishi N; Hirashima M; Middeldorp J; Busson P
    BMC Cancer; 2006 Dec; 6():283. PubMed ID: 17156439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.
    Sheu LF; Chen A; Wei YH; Ho KC; Cheng JY; Meng CL; Lee WH
    Am J Pathol; 1998 Jan; 152(1):63-74. PubMed ID: 9422524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of EB virus latent membrane protein 1 on mitosis control of nasopharyngeal carcinoma cell line CNE1].
    Liu B; Chen XY
    Ai Zheng; 2004 May; 23(5):512-6. PubMed ID: 15142445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma.
    Hu L; Troyanovsky B; Zhang X; Trivedi P; Ernberg I; Klein G
    Cancer Res; 2000 Oct; 60(19):5589-93. PubMed ID: 11034108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
    Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
    J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.